Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flunarizine in acute ischemic stroke: a pilot study.

M Limburg1, A Hijdra

  • 1Department of Neurology, Academisch Medisch Centrum, Amsterdam, The Netherlands.

European Neurology
|January 1, 1990
PubMed
Summary

Flunarizine, a calcium entry blocker, showed a potential benefit in treating acute supratentorial brain infarction. While not statistically significant, outcomes were better in the flunarizine group compared to placebo.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

School is more than a place to learn: An intersectoral assessment of adolescent well-being prior to and after the COVID-19 pandemic in the WHO European Region.

Public health in practice (Oxford, England)·2025
Same author

[Is there quality of life with locked-in syndrome?]

Nederlands tijdschrift voor geneeskunde·2018
Same author

Medical informatics in Amsterdam: Research and Education.

Yearbook of medical informatics·2016
Same author

Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?

BMC neurology·2016
Same author

Depressive symptoms and executive functioning in stroke patients: a follow-up study.

International journal of geriatric psychiatry·2010
Same author

A one-year follow-up study into the course of depression after stroke.

The journal of nutrition, health & aging·2010

Area of Science:

  • Neurology
  • Cardiovascular Pharmacology

Background:

  • Acute supratentorial brain infarction is a critical neurological condition.
  • Calcium entry blockers are investigated for neuroprotective effects.

Purpose of the Study:

  • To evaluate the efficacy of intravenous flunarizine in acute supratentorial brain infarction.
  • To compare outcomes between flunarizine treatment and placebo.

Main Methods:

  • Randomized, double-blind, placebo-controlled trial.
  • 26 patients with acute supratentorial brain infarction.
  • Treatment with flunarizine or placebo within 24 hours.
  • CT scan to exclude other pathologies.

Main Results:

  • Flunarizine group: 25% mortality or severe disability at 6 months.
  • Placebo group: 57% mortality or severe disability at 6 months.
  • A trend towards improved outcomes in the flunarizine group, though not statistically significant.

Conclusions:

  • Intravenous flunarizine may offer a clinically relevant benefit in acute supratentorial brain infarction.
  • Further research is warranted due to potential prognostic variable imbalances and confidence intervals.
  • The study suggests a possible role for calcium channel blockers in stroke management.

Related Experiment Videos